This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.
Sudisha Serani,
Faiza Shaikh,
Shraddha Bandager,
Raju Rathod,
Dhanshree R. karade,
- Student, Shree Ambabai Talim Sanstha’s, Diploma in Pharmacy college, Miraj, Maharashtra-4166410, India
- Student, Shree Ambabai Talim Sanstha’s, Diploma in Pharmacy college, Miraj, Maharashtra-4166410, India
- Faculty of Pharmacy, Shree Ambabai Talim Sanstha’s, Diploma in Pharmacy college, Miraj, Maharashtra-4166410, India
- Professor, Shree Ambabai Talim Sanstha’s, Diploma in Pharmacy college, Miraj, Maharashtra-4166410, India
- Professor, Shree Ambabai Talim Sanstha’s, Diploma in Pharmacy college, ,
Abstract
Medicinal plants are used in herbal medicine to treat and prevent illnesses. This includes the use of standardized and titrated botanical extracts in addition to common and traditional medicines from different cultures. The safety of a treatment may be suggested by its long history and deep cultural roots in traditional medical systems, but this does not always imply that it is effective. This is especially important in herbal medicine, since conventional treatments frequently use very low or ultra-low concentrations of active substances or are predicated on energy or magical concepts. In today’s globalized world, the relevance of evaluating the “transferability” of treatments across cultures is limited in clinical research. Instead, the focus should be on assessing efficacy and safety using the rigorous standards of mainstream clinical medicine. Another significant challenge in herbal treatments is the incomplete understanding of the precise composition of herbal extracts. To address this, modern biological technologies such as pharmacogenomics, metabolomics, and microarray methodologies are essential for thoroughly evaluating the pharmacological properties and safety of herbal remedies. Given the widespread and increasing global use of plant-derived substances, it is unwise to rely solely on traditional practices or supposed millennia-old beliefs. Both explanatory and pragmatic studies play a crucial role in generating reliable data, benefiting both healthcare providers and patients. Traditional medicine encompasses the entirety of practices rooted in the theories, beliefs, and experiences of various cultures and historical periods. Often enigmatic or not easily explained, these practices are used to maintain health and support the prevention, diagnosis, management, and treatment of illnesses. In every country, traditional medicine is often influenced by magical or religious beliefs, as well as collective popular experience. The World Health Organization (WHO) is actively working to develop comprehensive guidelines for clinical research methodologies and the evaluation of the effectiveness of traditional medicine practices.
Keywords: Science based medicine, Phytomedicine, Botanical medicine, Herbal therapy, Real world trials
Sudisha Serani, Faiza Shaikh, Shraddha Bandager, Raju Rathod, Dhanshree R. karade. Herbal Medicines and Complementary Therapies: Their Role, Types and Applications. Emerging Trends in Personalized Medicines. 2025; ():-.
Sudisha Serani, Faiza Shaikh, Shraddha Bandager, Raju Rathod, Dhanshree R. karade. Herbal Medicines and Complementary Therapies: Their Role, Types and Applications. Emerging Trends in Personalized Medicines. 2025; ():-. Available from: https://journals.stmjournals.com/etpm/article=2025/view=196697
References
- Evans WC. Trease and Evans’s Pharmacognosy. 15th ed. London: WB Saunders; 2001.
- Wani MS. Herbal medicine and its standardization. Pharm Rev. 2007;5(6).
- Voigt K. Our look at global burgeoning Asian herbal industry. Wall Street J. 2006 Jun 11.
- Dubey NK, Kumar R, Tripathi P. Global promotion of herbal medicine: India’s opportunity. Curr Sci. 2004;86:37‐41.
- Raskin I, Ribnick DM, Komamytsky S, Ilic N, Poulev A, Borisjuk N, et al. Plants and human health in the twenty-first century. Trends Biotechnol. 2002;20:522‐531.
- Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci. 2005;78:431‐441.
- Goldman P. Herbal medicine today and roots of modern pharmacology. Ann Intern Med. 2001;135:594‐600.
- Newman DG, Cragg GM. Natural product sources of new drugs over the last 25 years. J Nat Prod. 2007;70:461‐477.
- Prance GT. Floristic inventory of the tropics: Where do we stand? Ann Mo Bot Gard. 1997;64:659‐684.
- Mitscher LA, Pilla S, Shankel DM. Some transpacific thoughts on the regulatory need for standardization of herbal medicine. J Food Drug Anal. 2000;8:229‐234.
- O’Sullivan HM, Lum K. The poisoning of awa: the nontraditional use of an ancient remedy. Pac Health Dialog. 2004;11(2):211‐215.
- Ernst E. Contamination of herbal medicines. Pharm J. 2005;275:67‐168.
- De Smet PAGM. Health risks of herbal remedies: an update. Clin Pharmacol Ther. 2004;76(1):1‐17.
- World Health Organization (WHO). Regulatory situation of herbal medicine: A worldwide review. Geneva: WHO; 1998.
- National policy on traditional medicine and regulation of herbal medicines. Report of a WHO global survey. Geneva: WHO; 2005.
- WHO guidelines for developing consumer information on proper use of traditional medicines and complementary/alternative medicine. Geneva: WHO; 2004a.
- WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance system. Geneva: WHO; 2004b.
- WHO guidelines on Good Agriculture and Collection Practices (GACP) for medicinal plants. Geneva: WHO; 2003.
- Phillipson JD. Fifty years of medicinal plant research‐every progress in methodology is a progress in science. Planta Med. 2003;69:491‐495.
- Wang ZG, Ren J. Current status and future direction of Chinese herbal medicine. Trends Pharmacol Sci. 2002;23:347‐348.
- Tierra M. Founding Member of the American Herbalists Guild.
- Handa SS. Medicinal plants‐priorities in Indian medicines diverse studies and implications. In: Handa SS, Kakul MK, editors. Supplement to Cultivation and Utilization of Medicinal Plants. Jammu Tawi: Regional Research Laboratory, Council of Scientific and Industrial Research; 1996. p. 33‐51.
- Baer R, Ackerman A. Toxic Mexican folk remedies for the treatment of empacho: The case of azarcon, greta, and albayalde. J Ethnopharmacol. 1998;24:29‐31.
- Abu Melah A, Ahmad NA, Hassan AYEI. Traditional remedies and lead intoxication. Trop Geogr Med. 1987.
- Barnes J, Abbor NC. Experience with complementary remedies: A survey of community pharmacists. Pharm J. 1999;263:R37‐R43.
- Kayne S. A helping hand? Chemist Druggist. 2002;12:26‐28.
- Naido S, Wilkinson JM, Simpson MD. Attitudes of Australian pharmacists toward complementary and alternative medicines. Ann Pharmacother. 2005;39:1456‐1461.
- Welna EM, Hadsall RS, Schommer JC. Pharmacists’ personal use, professional practice behavior, and perception regarding herbal and other natural products. J Am Pharm Assoc. 2003.
- Shrivastava S, Dubey D, Kapoor S, Dubey P. The pharmacist’s role in herbal care. Medscape Pharm. 2007.
- Leaders FE. Incorporating botanical products into MCO formularies. Drug Benefit Trends. 1998;10:34‐43.
- Meinhardt RA, Richardson C, Ohlinger P. Alternative medicine and pharmacist counseling obligations. Drug Benefit Trends. 1998;10:24‐28.
- Ernst E. Complementary medicine pharmacist. Pharm J. 2004;273:197‐198.
- Ernst E. Recommended information sources. Pharm J. 2005;275:348.
- Nathan JP, Cicero LA, Koumis T, Rosenberg JMR, Feifer S, Maltz F. Availability and attitudes toward resources on alternative medicine products in the community pharmacy setting. J Am Pharm Assoc. 2005;45(6):734‐739.
- Patwardhan B. Indian drugs, Ayurveda: The designer medicine‐a review of ethnopharmacology and bioprospecting research. Indian Drugs. 2000;37(5):213‐227.
- Narayana DBA, Dobriyal M. How green are Indian and US pharmacopoeias. East Pharm. 2000;43(514):21‐24.
- Andersen PH, Jensen NJ. Mutagenic investigation of peppermint oil in the Salmonella/mammalian-microsome test. Mutat Res. 1984;138:17–20.
- Anderson IB, Mullen WH, Meeker JE, et al. Pennyroyal toxicity: Measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med. 1996;124:726–734.
- Bakerink JA, Gospe SM Jr, Dimand RJ, Eldridge MW. Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Pediatrics. 1996;98:944–947.
- Barce Loux DG. Pennyroyal and pulegone (Mentha pulegium L.). In: Medical Toxicology of Natural Substances: Foods, Fungi, Medicinal Herbs, Plants and Venomous Animals. Hoboken, NJ: John Wiley & Sons, Inc.; 2008. p. 563–567.
Emerging Trends in Personalized Medicines
Volume | |
Received | 30/11/2024 |
Accepted | 11/01/2025 |
Published | 01/02/2025 |